A case of age-related EBV-associated B-cell lymphoproliferative disorder metachronously showing two distinct morphologic appearances, one of a polymorphic disease resembling classical Hodgkin lymphoma, and the other of a large-cell lymphoma

International Journal of Hematology

Volumn 89, Issue 1, 2009, Pages 80-85

  Murase, Tadashi ^a,b   Fujita, Ayumi ^b   Ueno, Hironori ^b   Park, Jae Won ^b   Yano, Takahiro ^b   Hoshikawa, Masahiro ^c   Takagi, Masayuki ^c   Kuramochi, Shigeru ^b  

^a TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Age related EBV associated B cell lymphoproliferative disorders; Classical Hodgkin lymphoma; Epstein Barr virus; Non Hodgkin lymphoma

Indexed keywords

ACLACINOMYCIN; BLEOMYCIN; CD20 ANTIGEN; CYTARABINE; DACARBAZINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; OCTAMER TRANSCRIPTION FACTOR 2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; AXILLARY LYMPH NODE; B CELL LYMPHOPROLIFERATIVE DISEASE; CARDIOPULMONARY FUNCTION; CASE REPORT; CERVICAL LYMPHADENOPATHY; CLASSICAL HODGKIN LYMPHOMA; DEATH; DISEASE COURSE; DISEASE DURATION; DRUG WITHDRAWAL; GENERAL CONDITION DETERIORATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LOW DRUG DOSE; LYMPH NODE BIOPSY; LYMPHOPROLIFERATIVE DISEASE; MALE; MIXED CELLULARITY HODGKIN LYMPHOMA; MORPHOLOGICAL TRAIT; MULTIPLE CYCLE TREATMENT; PATIENT REFERRAL; SALVAGE THERAPY; SIDE EFFECT; TISSUE SECTION;

AGED; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE;

EID: 67349233127     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0214-0     Document Type: Article

References (19)

1. Borisch B, Raphael M, Swerdlow SH, Jaffe ES. Immunodeficiency associated lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 255-71.
2. T Oyama K Ichimura R Suzuki 2003 Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients Am J Surg Pathol 27 16 26 10.1097/00000478-200301000-00003
3. T Oyama K Yamamoto N Asano 2007 Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients Clin Cancer Res 13 5124 32 10.1158/1078-0432.CCR-06-2823
4. Laumen H, Nielsen PJ, Wirth T. The Bob.1/OBF.1 co-activtor is essential for octamer-dependent transcription in B cells. Eur J Immunol. 2000;30:458-69. doi:10.1002/1521-4141(200002)30:2<458::AID-IMMU458>3.0.CO;2-5.
5. H Stein T Marafioti HD Foss 2001 Down-regulation of Bob.1/OBF and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription Blood 97 496 501 10.1182/blood.V97.2.496
6. JG Krikorian JS Burke SA Rosenberg HS Kaplan 1979 Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease N Engl J Med 300 452 8
7. JO Armitage FR Dick JA Goeken MK Foucar RD Gingrich 1983 Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease Arch Intern Med 143 445 50 10.1001/archinte.143.3.445
8. MA Tucker CN Coleman RS Cox A Varghese SA Rosenberg 1988 Risk of second cancers after treatment for Hodgkin's disease N Engl J Med 318 76 81
9. MH Bennett KA MacLennan G Vaughan Hudson B Vaughan Hudson 1991 Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience Ann Oncol 2 suppl 2 83 92
10. A Zarate-Osorno LJ Medeiros DL Longo ES Jaffe 1992 Non-Hodgkin's lymphomas arising in patients successfully treated for Hodgkin's disease Am J Surg Pathol 16 885 95 10.1097/00000478-199209000-00007
11. FE van Leeuwen WJ Klokman A Hagenbeek 1994 Second cancer risk following Hodgkin's disease: a 20 year follow-up study J Clin Oncol 12 312 25
12. FE van Leeuwen WJ Klokman MB van't Veer 2000 Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood J Clin Oncol 18 487 97
13. U Rueffer A Josting J Franklin 2001 Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's lymphoma study group: incidence, treatment and prognosis J Clin Oncol 19 2026 32
14. GM Dores C Metayer RE Curtis 2002 Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years J Clin Oncol 20 3484 94 10.1200/JCO.2002.09.038
15. T Murase M Suzuki K Toyama 1986 Complete remission obtained by sequential chemotherapy of l-asparaginase and continuous infusion of bleomycin (ABLE protocol) in a case of refractory diffuse large cell lymphoma of a paranasal origin Rinsho Ketsueki 27 2 252 6
16. T Murase M Kondo 1987 Infusional bleomycin with l-asparaginase and/or BCNU as a salvage therapy for refractory lymphoid malignancies Exp Hematol 15 440
17. E Shiozawa B Saito T Yamochi-Onizuka 2007 Senile EBV-associated B-cell lymphoproliferative disorder of indolent clinical phenotype with recurrence as aggressive lymphoma Pathol Int 57 668 93 10.1111/j.1440-1827.2007.02158.x
18. RF Jarrett GL Stark J White 2005 Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma:a population-based study Blood 106 2444 51 10.1182/blood-2004-09-3759
19. Amini RM, Emblad G, Sundstroem C, Glimelius B. Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients. Int J Cancer. 1997;71:510-6. doi: 10.1002/(SICI)1097-0215(19970516)71:4<510::AID-IJC2>3. 0.CO;2-X.